HomeProductsBioactive CompoundsPI3K/Akt/mTOR PathwayPI3KCAS 1608125-21-8
Chemical structure of CAS 1608125-21-8

(alphaS)-7-Fluoro-alpha-methyl-N-9H-purin-6-yl-2-(2-pyridinyl)-3-quinolinemethanamine

CAS No.1608125-21-8
MDL No.MFCD28902228
MFC21H16FN7
MW385.40
InChI KeyKWRYMZHCQIOOEB-LBPRGKRZSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1608125-21-8
Product Name(alphaS)-7-Fluoro-alpha-methyl-N-9H-purin-6-yl-2-(2-pyridinyl)-3-quinolinemethanamine

Biological Targets

PIK3CD

Associated Conditions

chronic lymphocytic leukemia·head and neck squamous cell carcinoma·Mantle cell lymphoma·diffuse large B-cell lymphoma·cancer
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Distinct roles of PI3Kδ and PI3Kγ in a toluene diisocyanate-induced murine asthma model.

Toxicology • Vol. 454 • 2021
PMID: 33711354DOI: 10.1016/j.tox.2021.152747

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Discovery and in vivo evaluation of (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and related PI3Kδ inhibitors for inflammation and autoimmune disease.

Journal of medicinal chemistry • Vol. 58, Issue 1 • 2015
PMID: 25469863DOI: 10.1021/jm501624r

Documentation